Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Alkermes' VIVITROL medication for treatment of opioid dependence

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL(naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification.

13 Oct 2010

Lundbeck, Merck announce commercialization agreement for SYCREST sublingual tablets

H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.

12 Oct 2010

Synosia announces $30M Series C financing

Synosia Therapeutics, a privately held biotherapeutics company focused on neurology and psychiatry, today announced that it has raised $30M in a Series C financing round.

12 Oct 2010

UCB, Synosia Therapeutics announce new strategic partnership in neurology

UCB and Synosia Therapeutics announced today a new strategic partnership in neurology. Synosia has granted UCB a license for exclusive, worldwide rights to the development compound SYN-115 and rights to a second compound, SYN-118, for non-orphan indications. Both are in Phase II clinical development for the treatment of Parkinson's disease.

12 Oct 2010

Transition from child to adult mental health services poorly planned and executed

Many young people with mental health problems are at risk of falling through a huge gap in provision when they move from adolescent to adult care services, according to new research from the University of Warwick.

12 Oct 2010

TMS therapy benefits patients with major depression: Study

In a study to determine the durability and long-term effects of transcranial magnetic stimulation (TMS), psychiatric researchers at Rush University Medical Center have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in the October 2010 issue of Brain Stimulation, a journal published by Elsevier.

12 Oct 2010

FDA issues CRL to Jazz for JZP-6 NDA for fibromyalgia

Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.

11 Oct 2010

Researchers discover rhythmic changes in synapse numbers regulate sleep cycles

With the help of tiny, see-through fish, Stanford University School of Medicine researchers are homing in on what happens in the brain while you sleep. In a new study, they show how the circadian clock and sleep affect the scope of neuron-to-neuron connections in a particular region of the brain, and they identified a gene that appears to regulate the number of these connections, called synapses.

8 Oct 2010

Presbyterian Hospital collaborates with New York Center for Autism to establish Institute for Brain Development

NewYork-Presbyterian Hospital, along with its affiliated medical schools Columbia University College of Physicians and Surgeons and Weill Cornell Medical College, announced its collaboration with the New York Center for Autism to establish the Institute for Brain Development, a comprehensive, state-of-the-art institute dedicated to addressing the pressing clinical needs of individuals living with autism spectrum disorders and other developmental disorders of the brain, across their lifespan.

8 Oct 2010

ABMS awarded HHS contract to align meaningful use of HIT, ABMS MOC program

The American Board of Medical Specialties announced today a contract from the U.S. Department of Health and Human Services to align the meaningful use of health information technology and the ABMS Maintenance of Certification program, which was created by ABMS and its 24 Member Boards to promote lifelong learning and self assessment for physician specialists. The contract was awarded by the HHS Office of the National Coordinator for HIT.

8 Oct 2010

IMNG relaunches websites for Internal Medicine News, Hospitalist News

International Medical News Group, an Elsevier company that provides medical news to physicians, today announced the relaunch of its websites for Internal Medicine News (www.internalmedicinenews.com) and Hospitalist News.

8 Oct 2010

Hard combat can devastate veterans until old age

The trauma from hard combat can devastate veterans until old age, even as it influences others to be wiser, gentler and more accepting in their twilight years, a new University of Florida study finds.

8 Oct 2010

Childhood abuse may lead to physiological consequences later in life

Seemingly healthy adults, if they were abused or neglected during childhood, may suffer physiological consequences decades later. In research published online last week by the journal Neuropsychopharmacology, a team led by psychiatrists at Brown University and Butler Hospital found that healthy adults who reported being mistreated as kids appear to have an elevated inflammatory response to stress compared to adults who had happier childhoods.

8 Oct 2010

Patient personality can cause missed diagnoses of depression

Patient personality affects the accuracy of reports by friends and family members of mood history and symptoms and can cause missed diagnoses of depression, according to research published online by the journal International Psychogeriatrics.

8 Oct 2010

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Heart muscle cells do not normally replicate in adult tissue, but multiply with abandoned during development. This is why the loss of heart muscle after a heart attack is so dire-you can't grow enough new heart muscle to make up for the loss.

8 Oct 2010

HHS partners with PEPFAR to invest $130M for African medical education

The U.S. Department of Health and Human Services is partnering with the U.S. President's Emergency Plan for AIDS Relief with a plan to invest $130 million over five years to transform African medical education and dramatically increase the number of health care workers.

7 Oct 2010

Sudden cardiac arrest survivors to gather at SCAA Annual Meeting

A nationwide gathering of sudden cardiac arrest (SCA) survivors, emergency responders and civilian rescuers will mark SCA Awareness Month with a Survivors & Heroes Celebration on Friday, October 8 at 6:00 p.m. at the Marriott City Center in Pittsburgh, Pennsylvania.

7 Oct 2010

Fisher Wallace Laboratories launches easy-to-use medical device for depression treatment

Fisher Wallace Laboratories today announced the launch of a bold YouTube video campaign that challenges the pharmaceutical drug industry and introduces the company's easy-to-use medical device prescribed for the self-treatment of depression: the Fisher Wallace Cranial Stimulator.

6 Oct 2010

Centre for Addiction and Mental Health selected as field trial sites for DSM-5 criteria

Toronto's Centre for Addiction and Mental Health (CAMH) has been selected as one of seven adult field trial sites in North America and the only site in Canada to test proposed diagnostic criteria for the American Psychiatric Association's (APA) fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM).

6 Oct 2010

Researchers to conduct trial to improve drug abstinence, relapse rates

A $15.7 million award from the National Institute on Drug Abuse (NIDA) is allowing researchers to see whether consistent exercise will help people abstain from stimulant abuse.

6 Oct 2010